SCHEMBL26344183

SCHEMBL26344183

Cc1ccc(Oc2ccc(F)c(CNc3nc(=O)n(C4CCOCC4)c(=O)[nH]3)c2)cn1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 5/20 0.41
▸ CHRM2 P08172 2/20 0.36
▸ CHRM4 P08173 2/20 0.36
▸ CHRM5 P08912 2/20 0.36
▸ CHRM1 P11229 2/20 0.36
▸ CHRM3 P20309 2/20 0.36
▸ KCNH2 Q12809 2/20 0.36
▸ P2RX3 P56373 2/20 0.35
▸ JAK2 O60674 2/20 0.35
▸ JAK3 P52333 2/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ FFAR4 Q5NUL3 4/20 0.34
▸ MTOR P42345 2/20 0.34
▸ TLR7 Q9NYK1 1/20 0.34
▸ DRD1 P21728 1/20 0.34
▸ PDE9A O76083 1/20 0.34
▸ PDE1C Q14123 1/20 0.34
▸ AKT1 P31749 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26345985 0.85 PDE2A (0.48) PDE2ACHRM2CHRM4CHRM5CHRM1
SCHEMBL26345799 0.84 CHRM2 (0.38) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL26344153 0.81 P2RX3 (0.39) P2RX3FFAR4PDE9A
SCHEMBL26344200 0.77 IDH1 (0.38) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL26344212 0.76 PDE9A (0.43) PDE2APDE9A
SCHEMBL29416735 0.72 CHRM2 (0.35) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL29416812 0.71 CHRM2 (0.35) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL26344029 0.69 ACACB (0.39) PDE2AP2RX3PDE9A
SCHEMBL29588826 0.68 CHRM2 (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL26662006 0.68 CHRM2 (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4249474-A1 TRIAZINE DIONE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) 2023-09-27 — — EP disclosed
Send feedback